Abstract
Structural variants including copy number variations (CNV) have gained widespread attention, especially in pharmacogenomics but for several genes functional relevance and clinical evidence are still lacking. Detection of CNVs in next-generation sequencing data is challenging but offers widespread applications. We developed a cohort-based CNV detection workflow to extract CNVs from read counts of targeted NGS of 340 genes involved in absorption, distribution, metabolism and excretion (ADME) of drugs. We applied our method to 150 human liver tissue samples and correlated identified CNVs to mRNA expression levels. In total, we identified 445 deletions (73%) and 167 duplications (27%) in 36 pharmacogenes including all well-known CNVs of CYPs, GSTs, SULTs, UGTs, numerous described rare CNVs of CYP2E1, SLC16A3 or UGT2B15 as well as novel observations, e.g., for SLC22A12, SLC22A17 and GPS2 (G Protein Pathway Suppressor 2). We were able to fine-map complex CNVs of CYP2A6 and CYP2D6 with exon resolution. Correlation analysis confirmed known expression patterns for common CNVs and suggested an influence on expression variability for some rare CNVs. Our straightforward CNV detection workflow can be easily applied to any NGS coverage data and helped to analyze CNVs in an ADME-NGS panel of 340 pharmacogenes to improve genotype–phenotype correlations.
Similar content being viewed by others
Availability of data and materials
The NGS dataset used and analyzed in the current study is available from the corresponding author on reasonable request. The Illumina expression array data are available through Gene Expression Omnibus (GEO) Series accession number GSE32504.
References
Ahlmann-Eltze C (2019) ggsignif: Significance Brackets for ‘ggplot2’. R package version 0.5.0. https://CRAN.R-project.org/package=ggsignif
Bánlaki Z, Doleschall M, Rajczy K, Fust G, Szilágyi A (2012) Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes. Genes Immun 13(7):530–535
Butler MW, Hackett NR, Salit J, Strulovici-Barel Y, Omberg L, Mezey J et al (2011) Glutathione S-transferase copy number variation alters lung gene expression. Eur Respir J 38(1):15–28
Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y et al (2010) Origins and functional impact of copy number variation in the human genome. Nature 464(7289):704–712
Craddock N, Hurles ME, Cardin N, Pearson RD, Plagnol V, Robson S et al (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464(7289):713–720
Di Iulio J, Fayet A, Arab-Alameddine M, Rotger M, Lubomirov R, Cavassini M et al (2009) In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenet Genomics 19(4):300–309
Dunnenberger HM, Crews KR, Hoffman JM, Caudle KE, Broeckel U, Howard SC et al (2015) Preemptive clinical pharmacogenetics implementation. Current programs in five US medical centers. Annu Rev Pharmacol Toxicol 55:89–106
Émond J-P, Labriet A, Desjardins S, Rouleau M, Villeneuve L, Hovington H et al (2019) Factors affecting interindividual variability of hepatic UGT2B17 protein expression examined using a novel specific monoclonal antibody. Drug Metab Dispos 47(5):444–452
Endrizzi K, Fischer J, Klein K, Schwab M, Nüssler A, Neuhaus P et al (2002) Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction. Anal Biochem 300(2):121–131
Friedrichsen M, Poulsen P, Wojtaszewski J, Hansen PR, Vaag A, Rasmussen HB (2013) Carboxylesterase 1 gene duplication and mRNA expression in adipose tissue are linked to obesity and metabolic function. PLoS One 8(2):e56861
Fukami T, Nakajima M, Maruichi T, Takahashi S, Takamiya M, Aoki Y et al (2008) Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes. Pharmacogenet Genomics 18(10):911–920
Gaedigk A, Twist GP, Leeder JS (2012) CYP2D6, SULT1A1 and UGT2B17 copy number variation. Quantitative detection by multiplex PCR. Pharmacogenomics 13(1):91–111
Gulilat M, Lamb T, Teft WA, Wang J, Dron JS, Robinson JF et al (2019) Targeted next generation sequencing as a tool for precision medicine. BMC Med Genomics 12(1):81
Haberl M, Anwald B, Klein K, Weil R, Fu C, Gepdiremen A et al (2005) Three haplotypes associated with CYP2A6 phenotypes in Caucasians. Pharmacogenet Genomics 15(9):609–624
Hahne F, Ivanek R (2016) Visualizing genomic data using gviz and bioconductor. Methods Mol Biol 1418:335–351
He Y, Hoskins JM, McLeod HL (2011) Copy number variants in pharmacogenetic genes. Trends Mol Med 17(5):244–251
Hebbring SJ, Moyer AM, Weinshilboum RM (2008) Sulfotransferase gene copy number variation. Pharmacogenetics and function. Cytogenet Genome Res 123(1–4):205–210
Henrichsen CN, Vinckenbosch N, Zöllner S, Chaignat E, Pradervand S, Schütz F et al (2009) Segmental copy number variation shapes tissue transcriptomes. Nat Genet 41(4):424–429
Hoffman SM, Nelson DR, Keeney DS (2001) Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics 11(8):687–698
Hoh BP, Sam SS, Umi SH, Mahiran M, Nik Khairudin NY, Rafidah Hanim S et al (2014) A novel rare copy number variant of the ABCF1 gene identified among dengue fever patients from Peninsular Malaysia. Genet Mol Res 13(1):980–985
Kassambara A (2018) ggpubr: ‘ggplot2’ Based Publication Ready Plots. R package version 0.2. https://CRAN.R-project.org/package=ggpubr
Kerkhof J, Schenkel LC, Reilly J, McRobbie S, Aref-Eshghi E, Stuart A et al (2017) Clinical validation of copy number variant detection from targeted next-generation sequencing panels. J Mol Diagn 19(6):905–920
Kim I-W, Han N, Kim MG, Kim T, Oh JM (2015) Copy number variability analysis of pharmacogenes in patients with lymphoma, leukemia, hepatocellular, and lung carcinoma using The Cancer Genome Atlas data. Pharmacogenet Genomics 25(1):1–7
Klein K, Tremmel R, Winter S, Fehr S, Battke F, Scheurenbrand T et al (2019) A new panel-based next-generation sequencing method for ADME genes reveals novel associations of common and rare variants with expression in a human liver cohort. Front Genet 10:7
Kozyra M, Ingelman-Sundberg M, Lauschke VM (2017) Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response. Genet Med 19(1):20–29
Krepischi-Santos ACV, Rajan D, Temple IK, Shrubb V, Crolla JA, Huang S et al (2009) Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1. Cytogenet Genome Res 125(1):1–7
Kuroda Y, Ohashi I, Tominaga M, Saito T, Nagai J-I, Ida K et al (2014) De novo duplication in a patient with intellectual disability and obesity. Am J Med Genet A 164A(6):1550–1554
Lauschke VM, Ingelman-Sundberg M (2019) Prediction of drug response and adverse drug reactions. From twin studies to next generation sequencing. Eur J Pharm Sci 130:65–77
Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26(5):589–595
Ma I, Allan AL (2011) The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 7(2):292–306
Martis S, Mei H, Vijzelaar R, Edelmann L, Desnick RJ, Scott SA (2013) Multi-ethnic cytochrome-P450 copy number profiling. Novel pharmacogenetic alleles and mechanism of copy number variation formation. Pharmacogenomics J 13(6):558–566
Ménard V, Eap O, Harvey M, Guillemette C, Lévesque E (2009) Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism. Hum Mutat 30(9):1310–1319
Meyer UA (2004) Pharmacogenetics–five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 5(9):669–676
Meyer UA, Zanger UM, Schwab M (2013) Omics and drug response. Annu Rev Pharmacol Toxicol 53:475–502
Nord AS, Lee M, King M-C, Walsh T (2011) Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genomics 12:184
Numanagić I, Malikić S, Ford M, Qin X, Toji L, Radovich M et al (2018) Allelic decomposition and exact genotyping of highly polymorphic and structurally variant genes. Nat Commun 9(1):828
Oliveira C, Wolf T (2019) CNVPanelizer. Reliable CNV detection in targeted sequencing applications. R package version 1.4.0. https://bioconductor.org/packages/release/bioc/html/CNVPanelizer.html
Parajes S, Quinteiro C, Domínguez F, Loidi L (2008) High frequency of copy number variations and sequence variants at CYP21A2 locus. Implication for the genetic diagnosis of 21-hydroxylase deficiency. PLoS One 3(5):e2138
Pirmohamed M (2014) Personalized pharmacogenomics. Predicting efficacy and adverse drug reactions. Annu Rev Genomics Hum Genet 15:349–370
Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S et al (2012) A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics 28(21):2747–2754
Povysil G, Tzika A, Vogt J, Haunschmid V, Messiaen L, Zschocke J et al (2017) panelcn.MOPS. Copy-number detection in targeted NGS panel data for clinical diagnostics. Hum Mutat 38(7):889–897
Relling MV, Evans WE (2015) Pharmacogenomics in the clinic. Nature 526(7573):343–350
Rose-Zerilli MJ, Barton SJ, Henderson AJ, Shaheen SO, Holloway JW (2009) Copy-number variation genotyping of GSTT1 and GSTM1 gene deletions by real-time PCR. Clin Chem 55(9):1680–1685
Ruderfer DM, Hamamsy T, Lek M, Karczewski KJ, Kavanagh D, Samocha KE et al (2016) Patterns of genic intolerance of rare copy number variation in 59,898 human exomes. Nat Genet 48(10):1107–1111
Santos M, Niemi M, Hiratsuka M, Kumondai M, Ingelman-Sundberg M, Lauschke VM et al (2018) Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics. Genet Med 20(6):622–629
Schaeffeler E, Schwab M, Eichelbaum M, Zanger UM (2003) CYP2D6 genotyping strategy based on gene copy number determination by TaqMan real-time PCR. Hum Mutat 22(6):476–485
Schärfe CPI, Tremmel R, Schwab M, Kohlbacher O, Marks DS (2017) Genetic variation in human drug-related genes. Genome Med 9(1):117
Schröder A, Klein K, Winter S, Schwab M, Bonin M, Zell A et al (2013) Genomics of ADME gene expression. Mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver. Pharmacogenomics J 13(1):12–20
Slowikowski K (2018) ggrepel: Automatically Position Non-Overlapping Text Labels with ‘ggplot2’. R package version 0.8.0. https://CRAN.R-project.org/package=ggrepel
Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmöller J, Roots I et al (2000) Characterization of the glutathione S-transferase GSTT1 deletion. Discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 10(6):557–565
Tremmel R, Klein K, Winter S, Schaeffeler E, Zanger UM (2016) Gene copy number variation analysis reveals dosage-insensitive expression of CYP2E1. Pharmacogenomics J 16(6):551–558
Tremmel R, Herrmann K, Engst W, Meinl W, Klein K, Glatt H et al (2017) Methyleugenol DNA adducts in human liver are associated with SULT1A1 copy number variations and expression levels. Arch Toxicol 91(10):3329–3339
van der Wouden CH, Cambon-Thomsen A, Cecchin E, Cheung KC, Dávila-Fajardo CL, Deneer VH et al (2017) Implementing pharmacogenomics in Europe. Design and implementation strategy of the ubiquitous pharmacogenomics consortium. Clin Pharmacol Ther 101(3):341–358
Wickham H (2017) tidyverse: Easily Install and Load the ‘Tidyverse’. R package version 1.2.1. https://CRAN.R-project.org/package=tidyverse
Woodwark C, Bateman A (2011) The characterisation of three types of genes that overlie copy number variable regions. PLoS One 6(5):e14814
Xu S, Wang Y, Roe B, Pearson WR (1998) Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion. J Biol Chem 273(6):3517–3527
Yang W, Zhang Y, Fu F, Li R (2013) High-resolution array-comparative genomic hybridization profiling reveals 20q13.33 alterations associated with ovarian endometriosis. Gynecol Endocrinol 29(6):603–607
Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism. Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138(1):103–141
Zhou J, Lemos B, Dopman EB, Hartl DL (2011) Copy-number variation. The balance between gene dosage and expression in Drosophila melanogaster. Genome Biol Evol 3:1014–1024
Acknowledgements
We thank Dr. Florian Büttner for statistical expertise and discussions. The excellent technical assistance of Igor Liebermann is gratefully acknowledged. This study was supported by the Robert Bosch Foundation, Stuttgart, Germany and the European Commission Horizon 2020-PHC-2015 Grant U-PGx 668353.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
SF, FB, TS, and SB were employed by CeGaT GmbH, Tübingen. The remaining authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tremmel, R., Klein, K., Battke, F. et al. Copy number variation profiling in pharmacogenes using panel-based exome resequencing and correlation to human liver expression. Hum Genet 139, 137–149 (2020). https://doi.org/10.1007/s00439-019-02093-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-019-02093-7